Tumor therapy with Amanita phalloides (Death Cap): stabilization of mammary duct cancer

다국어 초록 (Multilingual Abstract)

Molecular events that cause tumor formation enhance a number of HOX genes, called switch genes, coding for RNApolymeraseII transcription factors. Thus, in tumor cells, RNApolymeraseII is more active than in other somatic cells. Amanita phalloides contains amanitin which inhibits RNApolymeraseII. Partial inhibition with amanitin influences tumor cell - but not normal cell - activity. To widen the treatment spectrum, dilutions of Amanita phalloides, containing amanitin, are applied to a patient with mammary duct cancer. For monitoring tumormarkers, different doses of amanitin are applied. The former duplication time of tumor growth represented three months; however within a period of 18 months the patient can be stabilized without further growth of the tumor. There are also no severe symptoms, no liver damage and no continuous erythrocyte deprivation. This new principle of tumor therapy shows high potential to provide a medical treatment.

참고문헌 (Reference)

1 Bishop JM, "Viral oncogenes" 42 : 23-38, 1985

2 Rozovskaia T, "Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality" 20 : 874-878, 2001

3 Riede, I, "Tumor Therapy with Amanita phalloides (Death Cap): Stabilization of B-Cell Chronic Lymphatic Leukemia" 16 : 1129-1132, 2010

4 Yang ZQ, "Transforming properties of 8p11-12 amplified genes in human breast cancer" 70 : 8487-8497, 2010

5 Gu Y, "The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene" 71 : 701-708, 1992

6 Riede I, "Switch Genes in Tumor Formation" 87 : 54-59, 2004

7 Barrett JC, "Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis" 39 : 45-56, 1986

8 Riede I, "Proliferative genes induce somatic pairing defects in Drosophila melanogaster and allow replication" 97 : 143-154, 1997

9 Imam JS, "MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogen in human cancers" 29 : 4971-4979, 2010

10 Orlovsky K, "Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation" 108 : 7956-7961, 2011

11 Svingen T, "Altered HOX gene expression in human skin and breast cancer cells" 2 : 518-523, 2003